Dermatological Congress Research Articles

Abstracts of the scientific communications presented at the 34th European Veterinary Dermatology Congress Organized by ESVD-ECVD, Gothenburg, Sweden, 31 August-2 September 2023.

Abstracts of the scientific communications presented at the 34th European Veterinary Dermatology Congress Organized by ESVD-ECVD, Gothenburg, Sweden, 31 August-2 September 2023.

What did Ottoman doctor Hüseyin Hulki (1862-1894) speak about at the first International Dermatology Congress?

What did Ottoman doctor Hüseyin Hulki (1862-1894) speak about at the first International Dermatology Congress?

The 25th World Congress of Dermatology, Singapore, 3-8 July, 2023: Research Highlights.

The 25th World Congress of Dermatology, Singapore, 3-8 July, 2023: Research Highlights.

Equine allergic skin diseases: Clinical consensus guidelines of the World Association for Veterinary Dermatology.

Allergic skin diseases are common in horses worldwide. The most common causes are insect bites and environmental allergens. To review the current literature and provide consensus on pathogenesis, diagnosis, treatment and prevention. The authors reviewed the literature up to November 2022. Results were presented at North America Veterinary Dermatology Forum (2021) and European Veterinary Dermatology Congress (2021). The report was available to member organisations of the World Association for Veterinary Dermatology for feedback. Insect bite hypersensitivity (IBH) is the best characterised allergic skin disease. An immunoglobulin (Ig)E response against Culicoides salivary antigens is widely documented. Genetics and environmental factors play important roles. Tests with high sensitivity and specificity are lacking, and diagnosis of IBH is based on clinical signs, seasonality and response to insect control. Eosinophils, interleukin (IL)-5 and IL-31 are explored as therapeutic targets. Presently, the most effective treatment is insect avoidance. Existing evidence does not support allergen-specific immunotherapy (ASIT) using commercially available extracts of Culicoides. Hypersensitivity to environmental allergens (atopic dermatitis) is the next most common allergy. A role for IgE is supported by serological investigation, skin test studies and positive response to ASIT. Prospective, controlled, randomised studies are limited, and treatment relies largely on glucocorticoids, antihistamines and ASIT based on retrospective studies. Foods are known triggers for urticaria, yet their role in pruritic dermatitis is unknown. Recurrent urticaria is common in horses, yet our understanding is limited and focussed on IgE and T-helper 2 cell response. Prospective, controlled studies on treatments for urticaria are lacking. Glucocorticoids and antihistamines are primary reported treatments.

Long-term follow-up of epidermolysis bullosa in real practice shows stability of the Epidermolysis Bullosa Disease Activity and Scarring Index and improvement with some off-label therapies

Long-term follow-up of epidermolysis bullosa in real practice shows stability of the Epidermolysis Bullosa Disease Activity and Scarring Index and improvement with some off-label therapies

THE 4TH NATIONAL CONGRESS OF AESTHETIC DERMATOLOGY

On 27th and 28th November 2020, the 4th National congress of aesthetic dermatology was organized in Can Tho province – the biggest city of Mekong Delta after long delay because of Covid-19 pandemic. This annual event was one of the most remarkable occasions of the year which aimed to advance excellence in aesthetic medicine area. The congress attracted numerous scientists, physicians and experts from all over the country who involved in dermatology practice.

Abstracts from the 35th Nordic Congress of Dermatology & Venereology, the NCDV 2022

Abstracts from the 35th Nordic Congress of Dermatology & Venereology, the NCDV 2022

Ulusal Türk Dermatoloji Kongresi'nde Sunulan Bildirilerin Kaderi: Tanımlayıcı Araştırma

Objective: The aim of the present study is to evaluate the publication rates of the abstracts presented at the National Dermatology Congress and the consistency between the abstracts and the article. Material and Methods: 27th National Dermatology Congress was chosen as a reference. A total of the 339 oral presentations (OPs) and poster presentations (PPs) in the congress booklet were included. PubMed, Google Scholar and TR Index search engines were used to search for the full-text articles of the presentations. The type of presentation, the clinic from which it was sent, the number of authors, and the dermatological disease group, the type of the presentation published as an article, its consistency with the abstract, the journal index, the type of publication, the number of citations, the number of months until publication were evaluated. Results: The mean number of authors in the presentations was 3.64±1.88, the mean time until publication was 28.44±9.84 months. A total of 65 (19.2%) OPs and 274 (80.8%) PPs were presented. Universities were the clinics that presented the highest number of abstracts (p<0.05). A total of 57 (16.2%) abstracts were published as articles. Papulosquamous disorders were the most frequently presented disease group with 71 (20.9%) presentations. OPs were published mean 29.64±6.12 months alter and PPS were published mean 27.84±11.16 months later. The publication and citation rate of OPs were higher than that of PPs (p<0.05). OPs were more likely to be original studies and PPs were more likely to be case reports (p<0.05). Inconsistency was detected in 29 (50.8%) of the presentations that were published as articles. Inconsistency rate of PPs was found to be higher (p<0.05). Conclusion: The National Turkish Dermatology Congress is generally productive, similar quality when compared to national congresses and low quality when compared to international congresses.

32nd European Veterinary Dermatology Congress (online) 16-16 September 2021 Abstracts.

32nd European Veterinary Dermatology Congress (online) 16-16 September 2021 Abstracts.

Pioneers in Dermatology and Venereology: an interview with Professor Ricardo Luis Galimberti.

Pioneers in Dermatology and Venereology: an interview with Professor Ricardo Luis Galimberti.

What's driving dermatology? Contribution title analysis of the largest German Dermatology Congress 2019.

BackgroundEvery two years, German-speaking dermatologic specialist groups gather in Berlin to share the latest developments at Germanýs largest dermatologic conference, the Annual Meeting of the Germany Society of Dermatology (DDG). Because this conference has a lasting effect on dermatologic practice and research, understanding what is moving the specialist groups means understanding what is driving dermatology in Germany.MethodsWe used word network analysis to compile and visualize the information embedded in the contribution titles to the DDG Annual Meeting in 2019. We extracted words, contributing cities and inter-connections. The data was standardized, visualized using network graphs and analyzed using common network analysis parameters.ResultsA total of 5509 words were extracted from 1150 contribution titles. The most frequently used words were “therapy”, “patients”, and “psoriasis”. The highest number of contributions came from Hamburg, Berlin and Munich. High diversity in research topics was found, as well as a well-connected research network.ConclusionsFocus of the well-connected German-speaking dermatology community meeting 2019 was patient and therapy centered and lies especially on the diseases psoriasis and melanoma. Network graph analysis can provide helpful insights and help planning future congresses. It can facilitate the choice which contributors to include as imbalances become apparent. Moreover, it can help distributing the topics more evenly across the whole dermatologic spectrum.

Changes in Chinese patch testing practices over 13 years: Updated cross-sectional survey and possible international implications.

Patch testing, the standard method for diagnosing allergic contact dermatitis, has been utilized for over 30 years in China. A 2006 survey found that patch testing was widespread among Chinese dermatologists, but the practice and perceptions were unsatisfactory. To evaluate the current situation of patch testing practice and perception, we resurveyed Chinese dermatologists. A cross-sectional survey of Chinese dermatologists was conducted by electronic questionnaires at the 15th National Congress of Dermatology in November 2019. There were 2199 valid questionnaires collected. About 75% of dermatologists performed patch testing; the majority (59.2%) utilized the baseline (standard) allergen series made in China; others used TRUE Test or the Chemotechnique Diagnostics series, a greater share compared with 2006. Most (92.8%) performed only one single reading, more than 2006. About two-thirds offered patient education after patch testing, but only 27% were executed by trained dermatologists. Dermatologists from regional hospitals more likely performed patch testing and had better perception of patch testing. The majority (88.1%) had received patch testing training, which however did not significantly improve dermatologists' perception. There was an insignificant improvement in practice and perception of dermatologists compared with 2006. Further education and studies should be conducted. Similar surveys in other countries would be of interest.

Attendee Survey and Practical Appraisal of a Telegram®-Based Dermatology Congress During the COVID-19 Confinement

IntroductionThe COVID-19 pandemic outbreak introduced dramatic changes in all our lives, daily practice, and medical conferences. In search of a tool to spread dermatologic knowledge during confinement, an online medical meeting was held on April 25th to 26th, 2020. In this study, we aimed to assess the characteristics, opinion and satisfaction of the attendees to a free-of-charge online congress. Secondarily, we intended to explain how this meeting was prepared. Material and MethodsOnline survey administered to the attendees to an online congress organised via the Telegram® Messenger App. Its organisation and planning, which needed no financial support and was done by volunteer organisers, moderators and speakers, is described step by step. ResultsThe satisfaction of both speakers and attendees was very high. All participants considered that this format had a great present and future, and most of them rated it as superior to regular face-to-face meetings. Female gender and predominantly private practice favoured this opinion. DiscussionThe COVID-19 pandemic has forced the cancellation of most scientific gatherings. This has been seen by some authors as an excellent opportunity, encouraging medical societies and organisations to lead the change to virtual meetings. Although confinement did not allow real contact, our online meeting showed it was possible to ensure interaction and participation between attendees, moderators and speakers. Dermatologists enjoyed some dermatologic science, even despite the extraordinary circumstances disrupting their daily clinical practice. Most of them felt they were participating in something new and compelling that many felt superior to traditional meetings.

Pioneers in Dermatology and Venereology: An interview with Prof. Nikolay Tsankov.

Pioneers in Dermatology and Venereology: An interview with Prof. Nikolay Tsankov.

Calcipotriol/betamethasone dipropionate aerosol foam in the treatment of psoriasis: new perspectives for the use of an innovative topical treatment from real-life experience.

The fixed-dose combination of calcipotriol/betamethasone dipropionate (Cal/BD foam) in aerosol foam formulation is approved for the treatment of plaque psoriasis, and showed prompt onset of action, persistent efficacy and safety both in clinical trials and in real-life studies. The use of Cal/BD foam and its future perspectives of use were discussed during the symposium "Go beyond with topical treatment in psoriasis", held at the 2019 World Congress of Dermatology. We herein present the key topics of the symposium, namely the importance of Cal/BD foam in overcoming poor adherence, the possibility of a proactive (long-term) management of psoriasis and its potential role beyond mild psoriasis. Furthermore, proper adherence to treatment is crucial to achieve optimal clinical outcomes. In clinical trials and real-life experiences, Cal/BD foam has proven to have a fast onset of action and a good benefit/risk ratio due to increased efficacy and similar safety profile compared with other Cal/BD formulations. Given its chronic nature, psoriasis requires a long-term management, also due to the presence of underlying 'silent' inflammation that persists beyond resolution of flares. Cal/BD foam appears a favorable treatment for long-term management, and a specific trial is ongoing to investigate this new proactive approach. Lastly, evidence both from clinical studies and real-life experiences supports the use of Cal/BD foam in patients with moderate-to-severe disease, and this approach also showed greater effectiveness over some non-biologic systemic treatments. Therefore, Cal/BD foam may be considered as the new gold standard in topical therapy for patients with plaque psoriasis.

24th World Congress of Dermatology

ABSTRACT The 24th World Congress of Dermatology was held in Milan, Italy, on June 11–15, 2019, under the auspices of the International League of Dermatological Societies. The Dermatology Nurses' Association and the British Dermatological Nursing Group, both sister societies of the International League of Dermatological Societies, coordinated a nursing scientific program and a half-day leadership meeting held during the World Congress. Overview of the nursing scientific program and outcomes of the half-day leadership meeting are described.

Diagnosis and treatment of demodicosis in dogs and cats: Clinical consensus guidelines of the World Association for Veterinary Dermatology.

Demodicosis is a common disease in small animal veterinary practice worldwide with a variety of diagnostic and therapeutic options. To provide consensus recommendations on the diagnosis, prevention and treatment of demodicosis in dogs and cats. The authors served as a Guideline Panel (GP) and reviewed the literature available before December 2018. The GP prepared a detailed literature review and made recommendations on selected topics. A draft of the document was presented at the North American Veterinary Dermatology Forum in Maui, HI, USA (May 2018) and at the European Veterinary Dermatology Congress in Dubrovnik, Croatia (September 2018) and was made available via the World Wide Web to the member organizations of the World Association for Veterinary Dermatology for a period of three months. Comments were solicited and responses were incorporated into the final document. In young dogs with generalized demodicosis, genetic and immunological factors seem to play a role in the pathogenesis and affected dogs should not be bred. In old dogs and cats, underlying immunosuppressive conditions contributing to demodicosis should be explored. Deep skin scrapings are the diagnostic gold standard for demodicosis, but trichograms and tape squeeze preparations may also be useful under certain circumstances. Amitraz, macrocyclic lactones and more recently isoxazolines have all demonstrated good efficacy in the treatment of canine demodicosis. Therapeutic selection should be guided by local drug legislation, drug availability and individual case parameters. Evidence for successful treatment of feline demodicosis is strongest for lime sulfur dips and amitraz baths.

Third Combined South African Congress of the Dermatology, Dermatologic Surgery, and Vitiligo Societies, Pretoria, Republic of South Africa.

Third Combined South African Congress of the Dermatology, Dermatologic Surgery, and Vitiligo Societies, Pretoria, Republic of South Africa.

28th Turkish National Dermatology Congress, September 24-28, 2019, Antalya, Turkey.

28th Turkish National Dermatology Congress, September 24-28, 2019, Antalya, Turkey.

New Discoveries and Updates on Cutaneous Adverse Drug Reactions Presented at the 24th World Congress of Dermatology, Milan, Italy, 2019.

New Discoveries and Updates on Cutaneous Adverse Drug Reactions Presented at the 24th World Congress of Dermatology, Milan, Italy, 2019.